Drug selection for lung cancer therapy using antibody-based arrays

Details for Australian Patent Application No. 2008276251 (hide)

Owner Prometheus Laboratories, Inc.

Inventors Singh, Sharat; Harvey, Jeanne

Agent Watermark

Pub. Number AU-A-2008276251

PCT Pub. Number WO2009/012140

Priority 60/949,820 13.07.07 US

Filing date 11 July 2008

Wipo publication date 22 January 2009

International Classifications

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/012140 Priority application(s): WO2009/012140

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008276252-Off-axis anti-reflective intraocular lenses

2008276240-Putters with enhanced alignment visualization